Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trial

医学 介绍 随机对照试验 家庭医学 干预(咨询) 临床试验 同行支持 物理疗法 护理部 内科学
作者
Tonderai Mabuto,Daniel M. Woznica,Pretty Ndini,D.Z. Moyo .,Munazza Abraham,Colleen F. Hanrahan,Salome Charalambous,Barry Zack,Stefan Baral,Jill Owczarzak,Christopher J. Hoffmann
出处
期刊:The Lancet HIV [Elsevier]
卷期号:11 (1): e11-e19 被引量:1
标识
DOI:10.1016/s2352-3018(23)00235-7
摘要

Background People released from correctional facilities face multifactorial barriers to continuing HIV treatment. We hypothesised that barriers faced in the first 6 months of community re-entry would be decreased by a multilevel group-based and peer-led intervention, the Transitional Community Adherence Club (TCAC). Methods We did a pragmatic, open-label, individually randomised controlled trial in five correctional facilities in Gauteng, South Africa. Participants aged 18 years and older and receiving antiretroviral therapy (ART) in correctional facilities were enrolled before release and randomly assigned (1:2) to either passive referral (usual care) or TCACs. TCACs followed a 12-session curriculum over 6 months and were facilitated by trained peer and social workers. Participants were followed up by telephone and in person to assess the primary outcome: post-release enrolment in HIV treatment services at 6 months from the date of release. We did an intention-to-treat analysis to determine the effectiveness of TCACs compared with usual care. The trial was registered with the South African National Clinical Trials Register (DOH-27–0419–605) and ClinicalTrials.gov (NCT03340428). This study is completed and is listed as such on ClinicalTrials.gov. Findings From March 1, to Dec 13, 2019, we screened 222 individuals and enrolled 176 participants who were randomly assigned 1:2 to the usual care group (n=59) or TCACs (n=117). 175 participants were included in the final analysis. In the usual care group, 21 (36%) of 59 participants had enrolled in HIV treatment services at 6 months, compared with 71 (61%) of 116 in the TCAC group (risk ratio 1·7, 95% CI 1·2–2·5; p=0·0010). No adverse events were reported. Interpretation We found strong evidence that a differentiated service delivery model with curriculum and peer support designed specifically to address the needs of people with HIV returning from incarceration improved the primary outcome of enrolment in HIV treatment services. Our approach is a reasonable model to build further HIV treatment continuity interventions for individuals in the criminal justice system in South Africa and elsewhere. Funding National Institute of Mental Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助Niercol采纳,获得20
刚刚
浅藏完成签到,获得积分10
1秒前
从容芮应助禾禾采纳,获得10
2秒前
打打应助科研通管家采纳,获得10
2秒前
浅尝离白应助科研通管家采纳,获得30
2秒前
HEIKU应助科研通管家采纳,获得10
2秒前
汉堡包应助科研通管家采纳,获得10
2秒前
2秒前
3秒前
3秒前
3秒前
HEIKU应助科研通管家采纳,获得10
3秒前
星辰大海应助科研通管家采纳,获得10
3秒前
山水有佳发布了新的文献求助10
5秒前
5秒前
6秒前
MLi发布了新的文献求助10
7秒前
leozhao完成签到,获得积分10
9秒前
陈元元K发布了新的文献求助10
9秒前
lwq发布了新的文献求助10
10秒前
10秒前
共享精神应助Reset采纳,获得10
11秒前
小娜完成签到,获得积分10
11秒前
12秒前
善学以致用应助xmfffff采纳,获得10
15秒前
阿巴阿巴发布了新的文献求助10
16秒前
小娜发布了新的文献求助10
16秒前
幸福糖豆发布了新的文献求助10
16秒前
zsn完成签到 ,获得积分10
17秒前
17秒前
CLAIR发布了新的文献求助10
17秒前
sansan发布了新的文献求助10
17秒前
18秒前
MathFun完成签到 ,获得积分10
18秒前
19秒前
mingkle应助陈元元K采纳,获得20
19秒前
白子双发布了新的文献求助10
20秒前
21秒前
23秒前
LL77发布了新的文献求助10
24秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3150225
求助须知:如何正确求助?哪些是违规求助? 2801322
关于积分的说明 7844073
捐赠科研通 2458853
什么是DOI,文献DOI怎么找? 1308673
科研通“疑难数据库(出版商)”最低求助积分说明 628556
版权声明 601721